Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Four UK charities have joined forces to campaign for a potentially sight-saving drug to be made available for people with diabetic macular oedema after the National Institute for Health and Clinical Excellence turned down an appeal for it to be used on the NHS.
Diabetes UK, JDRF, the Macular Disease Society and the Royal National Institute of Blind People are urging the manufacturer of Lucentis, Novartis, to rapidly agree a Patient Access Scheme with the Department of Health and NICE in order to reduce the cost of this treatment to the NHS and ensure the maximum number of people with DMO can benefit from the treatment without delay.
http://www.bedfordtoday.co.uk/news/...join_forces_to_fight_for_sight_drug_1_3297235
Diabetes UK, JDRF, the Macular Disease Society and the Royal National Institute of Blind People are urging the manufacturer of Lucentis, Novartis, to rapidly agree a Patient Access Scheme with the Department of Health and NICE in order to reduce the cost of this treatment to the NHS and ensure the maximum number of people with DMO can benefit from the treatment without delay.
http://www.bedfordtoday.co.uk/news/...join_forces_to_fight_for_sight_drug_1_3297235